Global Health Limited (MEDANTA.BO)
Global Health Limited operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Gurugram, HA, IN. The stock last traded at $1422.15, up 0.79% on the session, giving a market capitalisation of $381.62B. Its beta of 0.16 implies it has historically moved less than the broad market.
Operating within India, Global Health Limited delivers a comprehensive range of medical services. Its extensive portfolio encompasses crucial areas such as organ transplantation (including lung and liver), maternal and pediatric care, neonatology, and specialized oncology services like URO-oncology, surgical, and radiation oncology. The company also provides expertise in fields like pulmonology, orthopaedics, urology, endocrine surgery, gastroenterology, psychiatry, and ENT, alongside essential blood bank and chest care provisions. Further expanding its offerings, it addresses digestive and hepatobiliary conditions, musculoskeletal disorders, critical care, anesthesiology, endocrinology, diabetology, and nephrology. Additional medical departments include obstetrics, dermatology, ophthalmology, and dental services, complemented by offerings in Ayurvedic medicine. Known by its Medanta brand, the organization manages a network of five hospitals situated across Gurugram, Delhi, Indore, Ranchi, Patna, and Lucknow. Established in 2004, Global Health Limited maintains its headquarters in New Delhi, India.
Global Health Limited is most often compared with the following Healthcare names: